The Biobank Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Product (Biobanking Equipment, -Temperature Control Systems, -Incubators & Centrifuges, -Alarms & Monitoring Systems, -Accessories & Other Equipment, Biobanking Consumables, Laboratory Information Management Systems), By Service (Biobanking & Repository, Lab processing, Qualification/ Validation, Cold Chain Logistics, Other ServiceS), By Biospecimen Type (Human Tissues, Organs, Stem Cells, Others), By Type (Physical/Real Biobanks, -Tissue Biobanks, -Population Based Biobanks, -Genetic (DNA/RNA), -Disease Based Biobanks, Virtual Biobanks), By Application (Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics, Others).
The Biobank Market is experiencing notable growth, propelled by the increasing demand for biological specimens for research purposes and personalized medicine. Biobanks store and manage various types of biological samples, including tissues, blood, and DNA, with associated clinical and demographic information. This market caters to academic institutions, pharmaceutical companies, and research organizations conducting studies on genetics, biomarkers, and disease mechanisms. Manufacturers in the Biobank Market are investing in advanced storage and retrieval systems, as well as ensuring compliance with ethical and regulatory standards. With the growing emphasis on precision medicine and translational research, the Biobank Market is poised for sustained expansion, playing a crucial role in advancing scientific discoveries and healthcare innovations.
The most prominent trend in the Biobank Market is the integration of big data and genomics into biobanking operations. Biobanks are increasingly incorporating advanced technologies to manage and analyze large-scale biological and clinical datasets. This trend involves leveraging big data analytics and genomic information to enhance sample storage, retrieval, and research capabilities. The integration of these technologies allows biobanks to play a pivotal role in personalized medicine, translational research, and the advancement of precision healthcare by providing valuable resources for the analysis of genetic and molecular data on a large scale.
A major driver propelling the Biobank Market is the growing emphasis on personalized medicine and biomarker discovery. With an increasing understanding of individual genetic variations and disease heterogeneity, there is a rising demand for high-quality biospecimens that support research in personalized treatment approaches. Biobanks serve as repositories of diverse biological samples, facilitating the identification of biomarkers for disease diagnosis, prognosis, and treatment response. The driver towards personalized medicine and the need for robust biomarker discovery platforms contribute to the expansion of biobanking activities, positioning them as crucial components in the advancement of precision medicine.
An emerging opportunity in the Biobank Market lies in the expansion of biobanks in emerging markets. Market players have the potential to capitalize on the growing awareness of the importance of biobanking and the increasing prevalence of chronic diseases in emerging economies. This opportunity involves establishing and enhancing biobanking infrastructure in these regions to meet the rising demand for biospecimens in research and clinical studies. Expanding biobanks in emerging markets not only supports global collaborative research efforts but also addresses the unique genetic diversity present in these populations, contributing to a more comprehensive understanding of diseases and improving the effectiveness of healthcare interventions on a global scale. Seizing this opportunity allows companies to be at the forefront of fostering international collaborations and advancing biobanking initiatives.
By Product
-Temperature Control Systems
-Incubators & Centrifuges
-Alarms & Monitoring Systems
-Accessories & Other Equipment
By Service
By Biospecimen Type
By Type
By Application
By Region
*list not exhaustive
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Biobank Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Biobank Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 INTRODUCTION TO 2024 Biobank Markets
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 RESEARCH METHODOLOGY
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 EXECUTIVE SUMMARY
3.1 Global Biobank Market Size Outlook, $ Million, 2021 to 2030
3.2 Biobank Market Outlook by Type, $ Million, 2021 to 2030
3.3 Biobank Market Outlook by Product, $ Million, 2021 to 2030
3.4 Biobank Market Outlook by Application, $ Million, 2021 to 2030
3.5 Biobank Market Outlook by Key Countries, $ Million, 2021 to 2030
4 MARKET DYNAMICS
4.1 Key Driving Forces of Biobank Market Industry
4.2 Key Market Trends in Biobank Market Industry
4.3 Potential Opportunities in Biobank Market Industry
4.4 Key Challenges in Biobank Market Industry
5 MARKET FACTOR ANALYSIS
5.1 Competitive Landscape
5.1.1 Global Biobank Market Share by Company
5.1.2 Product Offerings by Company
5.2 Porter’s Five Forces Analysis
6 GROWTH OUTLOOK ACROSS SCENARIOS
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 GLOBAL Biobank Market OUTLOOK BY SEGMENTS
7.1 Biobank Market Outlook by Segments
By Product
Biobanking Equipment
-Temperature Control Systems
-Incubators & Centrifuges
-Alarms & Monitoring Systems
-Accessories & Other Equipment
Biobanking Consumables
Laboratory Information Management Systems
By Service
Biobanking & Repository
Lab processing
Qualification/ Validation
Cold Chain Logistics
Other Service
By Biospecimen Type
Human Tissues
Organs
Stem Cells
Others
By Type
Physical/Real Biobanks
-Tissue Biobanks
-Population Based Biobanks
-Genetic (DNA/RNA)
-Disease Based Biobanks
Virtual Biobanks
By Application
Therapeutics
Drug Discovery & Clinical Research
Clinical Diagnostics
Others
8 NORTH AMERICA Biobank Market ANALYSIS AND OUTLOOK TO 2030
8.1 Introduction to North America Biobank Markets in 2024
8.2 North America Biobank Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Biobank Market size Outlook by Segments, 2021-2030
By Product
Biobanking Equipment
-Temperature Control Systems
-Incubators & Centrifuges
-Alarms & Monitoring Systems
-Accessories & Other Equipment
Biobanking Consumables
Laboratory Information Management Systems
By Service
Biobanking & Repository
Lab processing
Qualification/ Validation
Cold Chain Logistics
Other Service
By Biospecimen Type
Human Tissues
Organs
Stem Cells
Others
By Type
Physical/Real Biobanks
-Tissue Biobanks
-Population Based Biobanks
-Genetic (DNA/RNA)
-Disease Based Biobanks
Virtual Biobanks
By Application
Therapeutics
Drug Discovery & Clinical Research
Clinical Diagnostics
Others
9 EUROPE Biobank Market ANALYSIS AND OUTLOOK TO 2030
9.1 Introduction to Europe Biobank Markets in 2024
9.2 Europe Biobank Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Biobank Market size Outlook by Segments, 2021-2030
By Product
Biobanking Equipment
-Temperature Control Systems
-Incubators & Centrifuges
-Alarms & Monitoring Systems
-Accessories & Other Equipment
Biobanking Consumables
Laboratory Information Management Systems
By Service
Biobanking & Repository
Lab processing
Qualification/ Validation
Cold Chain Logistics
Other Service
By Biospecimen Type
Human Tissues
Organs
Stem Cells
Others
By Type
Physical/Real Biobanks
-Tissue Biobanks
-Population Based Biobanks
-Genetic (DNA/RNA)
-Disease Based Biobanks
Virtual Biobanks
By Application
Therapeutics
Drug Discovery & Clinical Research
Clinical Diagnostics
Others
10 ASIA PACIFIC Biobank Market ANALYSIS AND OUTLOOK TO 2030
10.1 Introduction to Asia Pacific Biobank Markets in 2024
10.2 Asia Pacific Biobank Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Biobank Market size Outlook by Segments, 2021-2030
By Product
Biobanking Equipment
-Temperature Control Systems
-Incubators & Centrifuges
-Alarms & Monitoring Systems
-Accessories & Other Equipment
Biobanking Consumables
Laboratory Information Management Systems
By Service
Biobanking & Repository
Lab processing
Qualification/ Validation
Cold Chain Logistics
Other Service
By Biospecimen Type
Human Tissues
Organs
Stem Cells
Others
By Type
Physical/Real Biobanks
-Tissue Biobanks
-Population Based Biobanks
-Genetic (DNA/RNA)
-Disease Based Biobanks
Virtual Biobanks
By Application
Therapeutics
Drug Discovery & Clinical Research
Clinical Diagnostics
Others
11 SOUTH AMERICA Biobank Market ANALYSIS AND OUTLOOK TO 2030
11.1 Introduction to South America Biobank Markets in 2024
11.2 South America Biobank Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Biobank Market size Outlook by Segments, 2021-2030
By Product
Biobanking Equipment
-Temperature Control Systems
-Incubators & Centrifuges
-Alarms & Monitoring Systems
-Accessories & Other Equipment
Biobanking Consumables
Laboratory Information Management Systems
By Service
Biobanking & Repository
Lab processing
Qualification/ Validation
Cold Chain Logistics
Other Service
By Biospecimen Type
Human Tissues
Organs
Stem Cells
Others
By Type
Physical/Real Biobanks
-Tissue Biobanks
-Population Based Biobanks
-Genetic (DNA/RNA)
-Disease Based Biobanks
Virtual Biobanks
By Application
Therapeutics
Drug Discovery & Clinical Research
Clinical Diagnostics
Others
12 MIDDLE EAST AND AFRICA Biobank Market ANALYSIS AND OUTLOOK TO 2030
12.1 Introduction to Middle East and Africa Biobank Markets in 2024
12.2 Middle East and Africa Biobank Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Biobank Market size Outlook by Segments, 2021-2030
By Product
Biobanking Equipment
-Temperature Control Systems
-Incubators & Centrifuges
-Alarms & Monitoring Systems
-Accessories & Other Equipment
Biobanking Consumables
Laboratory Information Management Systems
By Service
Biobanking & Repository
Lab processing
Qualification/ Validation
Cold Chain Logistics
Other Service
By Biospecimen Type
Human Tissues
Organs
Stem Cells
Others
By Type
Physical/Real Biobanks
-Tissue Biobanks
-Population Based Biobanks
-Genetic (DNA/RNA)
-Disease Based Biobanks
Virtual Biobanks
By Application
Therapeutics
Drug Discovery & Clinical Research
Clinical Diagnostics
Others
13 COMPANY PROFILES
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Thermo Fisher Scientific Inc.
Merck KGaA
Qiagen
Hamilton Company
Tecan Trading AG
Danaher Corporation
Becton, Dickinson, and Company (BD)
Biocision, LLC.
Taylor-Wharton
Charles River Laboratories
Lonza
Stemcell Technologies
Biovault Family
Promocell Gmbh
Precision Cellular Storage Ltd
14 APPENDIX
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Product
-Temperature Control Systems
-Incubators & Centrifuges
-Alarms & Monitoring Systems
-Accessories & Other Equipment
By Service
By Biospecimen Type
By Type
By Application
By Region
The global Biobank Market is one of the lucrative growth markets, poised to register a 8.5 growth (CAGR) between 2024 and 2032.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Thermo Fisher Scientific Inc., Merck KGaA, Qiagen, Hamilton Company, Tecan Trading AG, Danaher Corporation, Becton, Dickinson, and Company (BD), Biocision, LLC., Taylor-Wharton, Charles River Laboratories, Lonza, Stemcell Technologies, Biovault Family, Promocell Gmbh, Precision Cellular Storage Ltd
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume